CL2014003510A1 - Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas. - Google Patents

Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas.

Info

Publication number
CL2014003510A1
CL2014003510A1 CL2014003510A CL2014003510A CL2014003510A1 CL 2014003510 A1 CL2014003510 A1 CL 2014003510A1 CL 2014003510 A CL2014003510 A CL 2014003510A CL 2014003510 A CL2014003510 A CL 2014003510A CL 2014003510 A1 CL2014003510 A1 CL 2014003510A1
Authority
CL
Chile
Prior art keywords
treatment
composition
growth factors
blood plasma
neurodegenerative diseases
Prior art date
Application number
CL2014003510A
Other languages
English (en)
Spanish (es)
Inventor
Aldecoa Eduardo Anitua
Original Assignee
Biotechnology Inst I Mas D Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49111229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014003510(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotechnology Inst I Mas D Sl filed Critical Biotechnology Inst I Mas D Sl
Publication of CL2014003510A1 publication Critical patent/CL2014003510A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CL2014003510A 2012-08-09 2014-12-23 Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas. CL2014003510A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201200810A ES2442242B1 (es) 2012-08-09 2012-08-09 Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.

Publications (1)

Publication Number Publication Date
CL2014003510A1 true CL2014003510A1 (es) 2015-05-04

Family

ID=49111229

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003510A CL2014003510A1 (es) 2012-08-09 2014-12-23 Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas.

Country Status (17)

Country Link
US (2) US20140044795A1 (cg-RX-API-DMAC7.html)
EP (1) EP2883569B1 (cg-RX-API-DMAC7.html)
JP (1) JP6339568B2 (cg-RX-API-DMAC7.html)
KR (1) KR102149162B1 (cg-RX-API-DMAC7.html)
CN (1) CN104519961A (cg-RX-API-DMAC7.html)
AR (1) AR092086A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015002760A2 (cg-RX-API-DMAC7.html)
CA (1) CA2881075A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014003510A1 (cg-RX-API-DMAC7.html)
CO (1) CO7170177A2 (cg-RX-API-DMAC7.html)
ES (2) ES2442242B1 (cg-RX-API-DMAC7.html)
IN (1) IN2014MN02675A (cg-RX-API-DMAC7.html)
MX (1) MX357828B (cg-RX-API-DMAC7.html)
PE (1) PE20150616A1 (cg-RX-API-DMAC7.html)
RU (1) RU2696497C2 (cg-RX-API-DMAC7.html)
TW (1) TWI649084B (cg-RX-API-DMAC7.html)
WO (1) WO2014023860A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112672A1 (es) 2016-12-21 2018-06-28 Universidad De Chile Virus aav/igf2, metodo de tratamiento genetico y su uso en enfermedades relacionadas con mal plegamiento de proteinas tal como la enfermedad de huntington

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033813A1 (en) * 1998-12-09 2000-06-15 Chiron Corporation Administration of neurotrophic agents to the central nervous system
AR022333A1 (es) 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo Regenerador de tejido oseo
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
ES2221770B2 (es) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
JP5276982B2 (ja) * 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
EP2152240A4 (en) * 2007-06-08 2012-05-09 Healthpartners Res Foundation PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
ES2333498B1 (es) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
CA2699411A1 (en) * 2007-09-14 2009-03-19 Scil Technology Gmbh Neuroendocrine factors for treatment of degenerative diseases
PT2430977T (pt) * 2009-05-14 2020-03-26 Biotechnology Inst I Mas D Sl Método para a preparação de pelo menos um composto do sangue, e dispositivo de amostragem para utilização na realização do referido método
KR101114712B1 (ko) * 2009-10-23 2012-02-29 세원셀론텍(주) 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(prp)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
ES2369945B1 (es) * 2011-07-29 2012-10-15 Eduardo Anitua Aldecoa Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112672A1 (es) 2016-12-21 2018-06-28 Universidad De Chile Virus aav/igf2, metodo de tratamiento genetico y su uso en enfermedades relacionadas con mal plegamiento de proteinas tal como la enfermedad de huntington

Also Published As

Publication number Publication date
US20160184360A1 (en) 2016-06-30
JP2015524464A (ja) 2015-08-24
MX2015001677A (es) 2015-04-10
TW201408310A (zh) 2014-03-01
KR20150040860A (ko) 2015-04-15
ES2662385T3 (es) 2018-04-06
CN104519961A (zh) 2015-04-15
RU2015104076A (ru) 2016-09-27
KR102149162B1 (ko) 2020-08-31
IN2014MN02675A (cg-RX-API-DMAC7.html) 2015-08-28
MX357828B (es) 2018-07-25
WO2014023860A1 (es) 2014-02-13
TWI649084B (zh) 2019-02-01
RU2696497C2 (ru) 2019-08-02
EP2883569A1 (en) 2015-06-17
EP2883569B1 (en) 2017-12-20
JP6339568B2 (ja) 2018-06-06
CA2881075A1 (en) 2014-02-13
PE20150616A1 (es) 2015-05-25
BR112015002760A2 (pt) 2020-04-22
CO7170177A2 (es) 2015-01-28
US20140044795A1 (en) 2014-02-13
ES2442242B1 (es) 2014-11-25
ES2442242A1 (es) 2014-02-10
AR092086A1 (es) 2015-03-25

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
LT2887944T (lt) Alopregnanolonas, skirtas atsparios epileptinės būklės gydymui
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
IL237275A0 (en) Compounds for the treatment of paramoxovirus viral infections
LT2916860T (lt) Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą
HUE047198T2 (hu) Fitokannabinoidok emlõrák kezelésére
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
EP2738153A4 (en) PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE
ZA201403430B (en) 4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions
SG10201703677VA (en) Methods of treating s. aureus-associated diseases
EP2937326A4 (en) PREPARATION PROCESS FOR 1,3, 3,3-TETRAFLUORPROPEN
LT2782602T (lt) Nukleotidas dims0-150, skirtas lėtinio aktyvaus opinio kolito gydymui
LT2939665T (lt) Farmacinė kompozicija, skirta živ infekcijų gydymui
HUE051295T2 (hu) Módosított fibroblaszt növekedési faktorok-1 szembetegségek kezelésére
IL243637B (en) PPAR-sparing compounds for the treatment of metabolic diseases
GB201121940D0 (en) Drug treating high blood pressure
IL238545A0 (en) Plants for production of therapeutic proteins
SG11201508061UA (en) Artificial transcription factors for the treatment of diseases caused by opa1 haploinsufficiency
EP2819995A4 (en) PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
ZA201302639B (en) Antibodies for the treatment of hiv
IT1398032B1 (it) Transferrina per il trattamento di malattie autoimmuni.
IL235428A0 (en) A process for the preparation of cyclic endopeptides
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure